| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.31B | 10.26B | 14.42B | 39.89B | 12.40B | 9.78B |
| Gross Profit | 1.46B | 1.29B | 9.38B | 5.17B | 3.46B | 1.28B |
| EBITDA | 4.41B | 4.32B | 7.79B | 3.81B | 2.42B | 88.00M |
| Net Income | 4.28B | 4.20B | 7.53B | 3.67B | 2.27B | -94.00M |
Balance Sheet | ||||||
| Total Assets | 27.32B | 29.05B | 31.14B | 26.14B | 21.57B | 17.05B |
| Cash, Cash Equivalents and Short-Term Investments | 12.38B | 15.35B | 18.72B | 3.94B | 3.40B | 4.65B |
| Total Debt | 25.00M | 63.00M | 136.00M | 2.98B | 1.81B | 299.00M |
| Total Liabilities | 1.09B | 1.02B | 4.15B | 5.78B | 4.22B | 1.95B |
| Stockholders Equity | 26.23B | 28.02B | 26.99B | 20.36B | 17.35B | 15.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -185.00M | 18.76B | 30.00M | -3.04B | 1.43B |
| Operating Cash Flow | 0.00 | 26.00M | 18.78B | 53.00M | -3.03B | 1.45B |
| Investing Cash Flow | 0.00 | -216.00M | -11.00M | -22.00M | 445.00M | -36.00M |
| Financing Cash Flow | 0.00 | -3.17B | -3.98B | 504.00M | 1.42B | -299.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥131.32B | 11.31 | ― | 2.57% | 7.46% | 153.98% | |
73 Outperform | ¥810.71B | 16.12 | ― | 3.93% | 2.57% | -4.79% | |
68 Neutral | ¥1.96T | 62.58 | 2.23% | 3.07% | -7.68% | -73.03% | |
67 Neutral | ¥58.11B | 17.04 | ― | 5.78% | -30.85% | -38.79% | |
67 Neutral | ¥70.55B | 25.58 | ― | 1.37% | -5.02% | 186.97% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | ¥237.73B | 16.46 | ― | 3.45% | -4.87% | 26.27% |